Geron Corporation
Geron Corporation (GERN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
gern · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Geron Corporation (GERN) measures how much investors pay for each dollar of the company's trailing earnings. GERN's current PE ratio of N/A is calculated by dividing its stock price of $1.14 by its TTM earnings per share of -$0.10.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Geron CorporationYou GERN | $731M | N/A | — | -$0.10 |
 Arvinas, Inc. ARVN | $466M | N/A | — | -$1.24 |
 ArriVent BioPharma, Inc. Common Stock AVBP | $1.4B | N/A | — | -$4.32 |
 Day One Biopharmaceuticals, Inc. DAWN | $2.2B | N/A | — | -$1.04 |
 LENZ Therapeutics, Inc. LENZ | $211M | N/A | — | -$2.85 |
 Replimune Group, Inc. REPL | $727M | N/A | — | -$3.07 |
 Rezolute, Inc. RZLT | $410M | N/A | — | -$0.98 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.13 | — | |
2024-12-31 FY2024 | — | $-0.27 | — | |
2023-12-31 FY2023 | — | $-0.32 | — | |
2022-12-31 FY2022 | — | $-0.37 | — | |
2021-12-31 FY2021 | — | $-0.35 | — | |
2020-12-31 FY2020 | — | $-0.28 | — | |
2019-12-31 FY2019 | — | $-0.36 | — | |
2018-12-31 FY2018 | — | $-0.15 | — | |
2017-12-31 FY2017 | — | $-0.18 | — | |
2016-12-31 FY2016 | — | $-0.19 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Geron Corporation (GERN) measures how much investors pay for each dollar of the company's trailing earnings. GERN's current PE ratio of N/A is calculated by dividing its stock price of $1.14 by its TTM earnings per share of -$0.10.
Frequently asked questions
GERN pe ratio · 6 questionsGERN's current PE ratio is N/A as of 2026-06-08, based on a stock price of $1.14 and TTM EPS of -$0.10. Data sourced from Financial Modeling Prep via GERN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Geron Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08